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Neurobiology of Disease

Pharmacological and Genetic Reversal of Age-Dependent
Cognitive Deficits Attributable to Decreased presenilin
Function
Sean M. J. McBride,1,2* Catherine H. Choi,1,2,3* Brian P. Schoenfeld,1,2* Aaron J. Bell,1,2 David A. Liebelt,1,2
David Ferreiro,1,2 Richard J. Choi,1,2 Paul Hinchey,1,2 Maria Kollaros,1,2 Allison M. Terlizzi,1,2 Neal J. Ferrick,1,2
Eric Koenigsberg,1,2 Rebecca L. Rudominer,1,2 Ai Sumida,4 Stephanie Chiorean,4 Kathleen K. Siwicki,5
Hanh T. Nguyen,1,2 Mark E. Fortini,6 Thomas V. McDonald,1,2† and Thomas A. Jongens4†
1

Section of Molecular Cardiology and 2Departments of Medicine and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York
10461, 3Department of Dermatology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, 4Department of Genetics, University of
Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, 5Department of Biology, Swarthmore College, Swarthmore, Pennsylvania 19081,
and 6Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107

Alzheimer’s disease (AD) is the leading cause of cognitive loss and neurodegeneration in the developed world. Although its genetic and
environmental causes are not generally known, familial forms of the disease (FAD) are attributable to mutations in a single copy of the
Presenilin (PS) and amyloid precursor protein genes. The dominant inheritance pattern of FAD indicates that it may be attributable to
gain or change of function mutations. Studies of FAD-linked forms of presenilin ( psn) in model organisms, however, indicate that they
are loss of function, leading to the possibility that a reduction in PS activity might contribute to FAD and that proper psn levels are
important for maintaining normal cognition throughout life. To explore this issue further, we have tested the effect of reducing psn
activity during aging in Drosophila melanogaster males. We have found that flies in which the dosage of psn function is reduced by 50%
display age-onset impairments in learning and memory. Treatment with metabotropic glutamate receptor (mGluR) antagonists or
lithium during the aging process prevented the onset of these deficits, and treatment of aged flies reversed the age-dependent deficits.
Genetic reduction of Drosophila metabotropic glutamate receptor (DmGluRA), the inositol trisphosphate receptor (InsP3R), or inositol
polyphosphate 1-phosphatase also prevented these age-onset cognitive deficits. These findings suggest that reduced psn activity may
contribute to the age-onset cognitive loss observed with FAD. They also indicate that enhanced mGluR signaling and calcium release
regulated by InsP3R as underlying causes of the age-dependent cognitive phenotypes observed when psn activity is reduced.

Introduction
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by progressive impairments in memory and cognitive
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abilities with a typical late age onset, although in cases of early
onset familial Alzheimer’s disease (FAD), the onset can be as early
as the third decade of life. The histopathological hallmarks of AD
are amyloid plaques and neurofibrillary tangles in the brains of
afflicted patients (Alzheimer, 1907; Selkoe, 2002; Mattson, 2004;
Hardy, 2006; Small and Gandy, 2006). The majority of FAD cases
are linked to mutations in the Presenilin 1 and Presenilin 2 (PS1/
PS2) genes, with additional cases linked to mutations in the amyloid precursor protein (APP) gene. FAD cases exhibit dominant
inheritance pattern in which the disease is caused by a mutation
in a single copy of one of these three genes (Mattson, 2004; Shen
and Kelleher, 2007).
In humans as well as in animal and cell culture models of AD,
FAD-linked PS and APP mutations generally, although not in all
cases, result in an enhanced ratio of ␤-amyloid 1-42 (A␤1-42) to
A␤1-40 (Moehlmann et al., 2002; Schroeter et al., 2003; QiTakahara et al., 2005; Walker et al., 2005; Kumar-Singh et al.,
2006; Sambamurti et al., 2006; De Strooper, 2007; Isoo et al.,
2007; Shen and Kelleher, 2007; Shioi et al., 2007). This finding
and the dominant inheritance pattern of FAD has led to a model
suggesting that FAD-linked mutations in PS1, PS2, and APP lead
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to gain-of-function or change-of-function forms of PS or APP
protein (Hardy, 2006; Small and Gandy, 2006).
Studies in mice, Drosophila, and Caenorhabditis elegans indicate that FAD-linked presenilin mutations have reduced function
with respect to cleavage substrates (De Strooper, 2007; Shen and
Kelleher, 2007). Both loss-of-function mutations in presenilin
( psn) and FAD-linked mutations lead to an increase in GSK-3␤
activity, which is normally negatively regulated by presenilin and
may be a ␥-secretase-independent function (Baki et al., 2004;
Serban et al., 2005; Shioi et al., 2007). Finally, the high number of
different mutations in presenilin that give rise to FAD is more consistent with a loss-of-function mechanism as gain-of-function or
change-of-function mutations for a protein are normally considered
to be rare, particularly because the mutations in presenilin 1 are
spread throughout different portions of the protein (Saura et al.,
2004; De Strooper, 2007; Shen and Kelleher, 2007). Together, these
results suggest the possibility that a reduction in the functional activity of PS1 and PS2 contribute to the pathogenesis of FAD, including cognitive loss.
We investigate the effect of reducing psn function on cognition during aging as an approach to determine whether lowered
psn function (but not completely absent function) may contribute to
cognitive impairment. We find that reduction in psn function leads
to age-onset cognitive deficits. Through pharmacological and genetic studies, we identify misregulation of metabotropic glutamate
receptor (mGluR) signaling and inositol trisphosphate receptor
(InsP3R)-mediated calcium release, as causal for the observed ageonset cognitive dysfunction. The implications of these studies toward understanding and possibly treating certain aspects of AD are
discussed.

Materials and Methods
Drosophila strains and drug testing. Drosophila strains used in this study
are described in supplemental Table 1 (available at www.jneurosci.org as
supplemental material). The Drosophila strains were cultured as in the
study by McBride et al. (2005). Drugs were obtained from Tocris Cookson and solubilized according to the instructions of the manufacturer.
They were added to the fly food after cooling to the appropriate concentration. Concentrations used were based on dose–response testing performed in a previous study on the Drosophila fragile X mental retardation
gene dfmr1 mutants (McBride et al., 2005). Vehicle for each drug was
added to the appropriate control food for each experiment.
Behavioral training and testing. Virgin male flies were collected under
ether anesthesia within 4 h of eclosion. Virgin XX, yf females were collected on the day of eclosion and kept in food vials in groups of 10 –15.
Flies were aged in a 12 h light/dark cycle before behavioral training and
testing. All testing was performed during the relative light phase. Mated
females were 5 d old and observed to mate with a male the night before
training. The virgin females that were used as targets were 4 d old. All
male subjects were transferred to fresh control food the day before testing. Male flies were assigned to random groups for behavior training and
testing, which was performed blind (Siegel and Hall, 1979; Kane et al.,
1997; McBride et al., 1999). The total amount of time a male was engaged
in courtship activity while paired with an unanesthetized target female
during a test period of 10 min or until successful copulation occurred was
scored. A courtship index (CI) was calculated as the percentage of total
observation time spent courting (Siegel and Hall, 1979). Binning of naive
courtship behavior was performed as in the study by McBride et al.
(2005), except that the percentage of flies advancing to a particular stage
of courtship during the courtship interval was scored and compiled.
Locomotor testing was done as in the study by McBride et al. (2005).
Cell death and mushroom body morphological analysis. Terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling
(TUNEL) assays were performed according to Ye and Fortini (1999)
using a S7110 kit from Oncor. Brains were treated following the protocol
for imaginal discs. Acridine Orange stainings were performed according
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to Hériché et al. (2003). Analysis of stained brains was performed by
three-dimensional reconstruction of optic stacks taken at 0.5 m using a
Leica scanning confocal microscope. The number of cell death foci and
their relative position were tabulated for each genotype. Analysis of
mushroom body (MB) morphology was performed as described by
McBride et al. (2005).
Statistical analyses. CIs of tested males were subjected to arcsin square
root transformations to approximate normal distributions (Joiner and
Griffith, 1997; McBride et al., 1999). ANOVAs were performed on pairwise comparisons of arcsin transformed data to get critical p values. All
statistics were performed using Statview 3.0.

Results
Examination of the effect of decreased presenilin activity
during aging
Drosophila has a single psn gene ortholog, the protein sequence of
which is ⬃50% identical to human PS1 and PS2 (Boulianne et al.,
1997; Hong and Koo, 1997). The encoded presenilin protein is
expressed in a wide range of tissues, including the brain (Ye and
Fortini, 1998). Isolation and characterization of several loss-offunction mutants have revealed that psn is an essential gene, required for proper neurogenesis and Notch processing (Struhl and
Greenwald, 1999; Ye et al., 1999). Biochemical studies of the
Drosophila presenilin protein have shown that it is a component
of the ␥-secretase complex like its mammalian counterparts (De
Strooper, 2003; Hu and Fortini, 2003; Takasugi et al., 2003).
The underlying nature of the mutations in PS1 and PS2 that
give rise to FAD are unclear (Saura et al., 2004; Qi-Takahara et al.,
2005; Walker et al., 2005; Kumar-Singh et al., 2006; Sambamurti
et al., 2006; De Strooper, 2007; Hardy, 2007; Isoo et al., 2007;
Shen and Kelleher, 2007; Wolfe, 2007). However, studies in
model organisms indicate that the FAD-linked mutations may
result in a reduction of PS1 and PS2 activity (De Strooper, 2007;
Shen and Kelleher, 2007). This possibility suggests that some phenotypes associated with Alzheimer’s disease, including age-onset
cognitive loss, may be attributable to a reduction in overall PS
activity levels. To investigate this possibility further, we tested the
effect of reducing psn activity using known psn loss-of-function
alleles. We evaluated the learning and memory capabilities of
young adult flies heterozygous for a given psn mutant allele (hereafter referred to as “psn-het flies”), with only ⬃50% of the psn
found in wild-type (WT) control flies [the wild-type control
strain is Oregon-R (OreR), the background strain from which the
psn alleles we used in this study were derived)]. We then reevaluated their capabilities at an older age to determine whether any
age-related cognitive decline could be observed. We took advantage of the large number of psn alleles with diminished function
that have been obtained from several genetic screens. In total, 10
different loss-of-function alleles of psn were examined, to ensure
that any observed effects were not attributable to second site
mutations or other background effects and crossed each to our
WT OreR line (for a description of the alleles used, see Materials
and Methods and Supplemental Table 1, available at www.
jneurosci.org as supplemental material).
Examining naive courtship, learning, and memory in aged
control flies
Before embarking on an examination of the effects of aging on
psn-het flies, using the courtship based assays, we first needed to
establish a timeline in which courtship-based learning and memory were not affected in our control OreR (WT) flies. The effect of
aging on naive courtship and courtship conditioned learning and
memory has not been extensively characterized. The lifespan of
Drosophila is ⬃60 d (after eclosion, in adult form); therefore, a
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Figure 1. The behavior of young adult (5-d-old) and elderly adult (45-d-old) wild-type flies (OreR). A–E, Naive courtship, learning during training, and short-term memory were examined in WT
flies at 5 and 45 d of age. Mean ⫾ SEM CIs are plotted; n values are indicated above each bar for all groups. The levels of significance are indicated (*p ⬍ 0.05, **p ⬍ 0.01, ***p ⬍ 0.001). WT flies
are OreR. A, Naive courtship in 5-d-old WT (black bar) and 45-d-old WT (open bar) flies. B, Learning during training in 5-d-old WT flies. C, Learning during training in 45-d-old WT flies. D, Short-term
memory in 5-d-old WT flies. E, Short-term memory in 45-d-old WT flies. Thus, at 45 d of age, there is no significant change in naive courtship behavior or cognition in WT flies. The behavior of young
adult (5-d-old) psn-het flies. F–L, Naive courtship, learning during training, immediate recall, and short-term memory were examined in psn-het flies at 5 d of age. Psn-het males for the psn alleles
psn B3, psn C4, psn I2, psn K2, psn S3, psn C1, psn C2.1, psn EMS46, psn L(3)15, and psn L(3)14 were aged for 5 d after eclosion. psn-het males were tested for naive courtship (F ), learning during
training (G, H ), immediate recall (0 –2 min after training) (I, J ), and short-term memory (60 min after training) (K, L). No deficits in behavior or cognitive capabilities were detected in any of the tests
performed on the young adult psn-het flies.

5-d-old adult fly is relatively “young,” a 30-d-old fly is “moderately aged,” and a 45-d-old fly is relatively “old.”
Courting Drosophila males perform a characteristic sequence
of behaviors when paired with a female: orienting toward and
following the female, tapping her with his forelegs, vibrating one
wing, licking her genitalia, and attempting to copulate (Hall,
1994). The percentage of time the male spends performing any of
these behaviors toward a target during a defined period of time is
referred to as the CI (Siegel and Hall, 1979). We tested progressively older naive males and found that 45-d-old WT flies perform naive courtship as robustly as young 5-d-old flies (Fig. 1 A).
This indicates that there are no sensory impairments with age that
diminish courtship. Furthermore, the quality of this courtship
was not different between 5- and 45-d-old WT flies (supplemental Fig. S1, available at www.jneurosci.org as supplemental material), nor was the level of locomotor activity (supplemental Fig.
S2, available at www.jneurosci.org as supplemental material).
We next determined an age range within which learning and
memory would be intact in WT flies. Learning and memory can
be examined in Drosophila by assaying conditioned courtship
behavior. In conditioned courtship, a male fly learns to modify
his courtship behavior after experience with an unreceptive female (Siegel and Hall, 1979; Hall, 1994). Virgin females generally
respond to a courting male by mating. However, recently mated

females are unreceptive and have an overlapping but altered
pheromonal profile that naive males find less provocative than
that of virgin female targets (Ejima et al., 2007). A naive male
paired with a mated female will initially court her, but his courtship activity soon decreases. When this learning during training
(LDT) is quantified, by comparing the CI during the first 10 min
with a mated female to the CI of the last 10 min period of a 1 h
pairing, wild-type flies typically show a ⱖ40% decrease in courtship activity (Joiner and Griffith, 1997; Kane et al., 1997). Hence,
LDT is a form of behavioral plasticity but is distinct and separate
from courtship suppression assayed after training, which is a
form of associative memory (Tompkins et al., 1983; Ackerman
and Siegel, 1986). When a male is paired with a virgin female after
1 h of experience with a mated female, his courtship remains
depressed for 2–3 h (Siegel and Hall, 1979). This effect is not a
general suppression of all courtship activity, because trained
males do not modify their courtship of other pheromonally distinct targets (Ejima et al., 2005; Siwicki et al., 2005). After training
with a mated female, memory is measured as a decrease in CI
toward virgin females in trained males relative to naive controls.
In Drosophila, five phases of memory have been elucidated by
a combination of genetic and pharmacological dissection. There
is an immediate recall memory (immediate memory) at 0 –2 min
after training, short-term memory out to 1 h, medium-term
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Figure 2. Naive courtship, LDT, immediate recall, and short-term memory in 30-d-old (late middle aged) psn-het flies. psn-het males for the psn alleles psn B3, psn C4, psn I2, psn K2, psn S3, psn
C1, psn C2.1, psn EMS46, psn L(3)15, and psn L(3)14 were aged for 30 d after eclosion. Mean ⫾ SEM CIs are plotted. n values are indicated above each bar for all groups. The levels of significance are
indicated (**p ⬍ 0.01, ***p ⬍ 0.001). A, Naive courtship levels remained robust and only slightly reduced from 5-d-old psn-het flies (compare with Fig. 1 F) in all psn-het males. B, C, psn-het males
were tested for learning during training, and none of the psn-het males demonstrated at least a 40% reduction in courtship activity during the training session or a statistically significant reduction
in courtship behavior. Therefore, psn-het flies have an age-dependent impairment in learning during training. D, E, Immediate recall remained intact in all psn-het males. F, G, psn-hets were also
tested for short-term memory at 60 min after training. All lines failed to exhibit short-term memory, in contrast to their behavior at 5 d of age (Fig. 1 K, L).

memory out to 6 h, anesthesia-resistant memory out to 2 d, and
long-term memory lasting up to 9 d after training that appears to
be dependent on protein synthesis (Skoulakis and Grammenoudi, 2006). Intact short-term memory is dependent on intact
immediate recall. However, immediate recall and short-term
memory are distinct from LDT. Therefore, intact memory can
occur without LDT, and learning during training can occur without posttraining memory (Joiner and Griffith, 1997; Kane et al.,
1997; McBride et al., 2005).
To assess LDT, a male fly was placed in a training chamber
with a previously mated female for 1 h, and the amount of time
the male spent courting in the initial 10 min interval was compared with the time spent engaged in courtship in the final 10 min
interval. Normal LDT in 5-d-old WT flies is illustrated by a significant ⱖ40% decrease in courtship during the training (Fig.
1 B), and short-term memory is illustrated in 5-d-old WT flies by
a significant decrease in courtship toward virgin females 1 h after
training (Fig. 1 D). We found that 45-d-old WT flies also demonstrated intact LDT and short-term memory (Fig. 1C,E). These
studies indicate that the courtship-based learning and memory
paradigm can be used to study aging-related issues of cognition
and behavior in flies.
Naive courtship, LDT, and memory in young and aged adult
psn-het flies
Courtship was robust in naive males of all 10 psn-het genotypes
examined as young adults at 5 d of age (Fig. 1F). Naive males of these
psn-het genotypes also displayed the normal steps of courtship behavior and normal levels of locomotor activity (supplemental Figs.
S3, S4, available at www.jneurosci.org as supplemental material).

LDT at 5 d of age in all 10 psn-het genotypes was normal, as
evidenced by decreases of ⬎40% from initial CI to final CI during
training with mated females (Fig. 1G,H ). To examine the immediate recall memory at 5 d of age, we took males that had just
completed a 1 h training session with a previously mated female
and immediately placed them in a new chamber with a virgin
target female for a 10 min courtship assay. This CI was then
compared with the courtship level of naive males that had been
placed in a training chamber for 1 h with no female, before being
introduced to a virgin target female. Immediate recall was intact
in all 10 psn-het genotypes examined (Fig. 1 I, J ). To assay shortterm memory, the trained male was placed in a holding chamber
for 60 min and then subsequently placed in a testing chamber
with a virgin female target. Nine of the psn-het genotypes were
tested and found to have normal short-term memory at 5 d of age
(Fig. 1 K, L).
We next examined naive courtship and LDT in 30-d-old (late
middle age) psn-het males. No significant effect on the level of
naive courtship (Fig. 2 A), its quality (supplemental Fig. S5, available at www.jneurosci.org as supplemental material), locomotor
activity (supplemental Fig. S6, available at www.jneurosci.org as
supplemental material), or phototaxis or chemotaxis (data not
shown) was observed. However, males of all 10 different psn-het
genotypes failed to demonstrate the typical decrease in courtship
activity in LDT at 30 d of age (Fig. 2 B, C). Impaired LDT is a very
rare phenotype in Drosophila but has been seen previously in
young adult flies that have altered calcium/calmodulindependent kinase II or protein kinase C (PKC) expression or
activity (Joiner and Griffith, 1997; Kane et al., 1997). These re-
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sults demonstrate an age-dependent impairment in LDT in psnhet male flies by 30 d of age.
We next examined immediate recall and short-term memory
in the psn-het flies at 30 d of age. We found that males of all 10
different psn-het genotypes displayed intact immediate recall at
30 d of age (Fig. 2 D, E). Intact immediate recall of courtship
memory without intact LDT has been observed previously in young
adult Drosophila (Joiner and Griffith, 1997; Kane et al., 1997). Although immediate recall was intact, examination of short-term
memory in nine of the heterozygous mutant presenilin lines, at 30 d
of age, revealed that this form of memory was no longer intact (Fig.
2F,G). This is in contrast to 5-d-old psn-het and 45-d-old WT flies,
which exhibited intact short-term memory. This demonstrates that
there is an age-dependent impairment of short-term memory in
heterozygous psn loss-of-function flies.
Genetic interaction between psn and dfmr1
In an effort to identify novel pathways affected as a result of the
reduction in psn levels, we looked for genetic interactions between psn and other genes known to affect cognition and behavior that might play a role in presenilin signaling based on the
literature. Interestingly, we identified a strong genetic interaction
between psn and the Drosophila fragile X mental retardation gene
dfmr1. At 5 d of age, psn and dfmr1 heterozygous single-mutant
flies display normal naive courtship levels relative to their given
genetic background (supplemental Fig. S7, available at www.
jneurosci.org as supplemental material). However, 5-d-old flies
that are transheterozygous mutant for both psn and dfmr1 display
a severe reduction in naive courtship levels, which is rescued by
the introduction of one wild-type copy of a dfmr1 genomic rescue
construct. Such heterozygous synergistic genetic interactions are
rare and suggest that both genes act in one or more common
pathways important for normal naive courtship activity.
Prevention of age-dependent LDT and short-term memory
deficits with pharmacological treatment
To explore the possibility of pharmacologically rescuing some
of the age-dependent psn-het phenotypes and in light of the
genetic interaction between psn and dfmr1 described above,
we focused on treatments that rescue naive courtship and cognitive deficits in dfmr1 mutants. One pathway that is known to
be affected in both fly and mouse models of fragile X is mGluR
signaling (Huber et al., 2002; McBride et al., 2005; Yan et al.,
2005; Dölen et al., 2007; Bolduc et al., 2008). In previous
studies, we found that several of the phenotypes displayed by
the dfmr1 mutants, including naive courtship and memory,
could be rescued by treatment with antagonists of DmGluRA
and LiCl (McBride et al., 2005). More recent studies have also
observed this and have also found that similar rescue is obtained by genetic reduction of DmGluRA activity, the sole
Drosophila mGluR (Bolduc et al., 2008; Pan et al., 2008).
Our working model is that treatment of flies with both
lithium and antagonists of DmGluRA will increase cAMP signaling and may also decrease InsP3R-mediated calcium release
(Fig. 3A). Lithium inhibits GSK-3␤ activity by competing with
the magnesium-binding site and increasing phosphorylation
at serine 9 (Gould and Manji, 2005; Huang and Klein, 2006;
Jope and Roh, 2006). There is an antagonistic relationship between protein kinase A (PKA) and GSK-3␤; therefore, this acts to
upregulate the downstream effect of cAMP signaling because
GSK-3␤ can inhibit cAMP response element-binding protein
(CREB)-mediated gene transcription (Bullock and Habener,
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1998; Grimes and Jope, 2001; Mai et al., 2002; Tanji et al., 2002;
Hansen et al., 2004; Gould and Manji, 2005). Lithium also inhibits inositol polyphosphate 1-phosphatase (IPPase) (Acharya et
al., 1998) and inositol monophosphatase (IMPase) (Berridge,
1993), thereby reducing the pool of InsP3 available to stimulate
InsP3R-mediated calcium signaling (Berridge, 1993; Takei et al.,
1998; Williams et al., 2002). Previous heterologous cell-based
studies have shown that DmGluRA can couple to heterotrimeric
Gi, leading to decreases in cAMP levels (Parmentier et al., 1996).
More recent in vivo studies have shown that DmGluRA also has
properties typically found associated with Gq-coupled group I
mGluRs such as regulating synaptic morphology and AMPA receptor presentation (Bogdanik et al., 2004; Pan and Broadie,
2007; Pan et al., 2008). Thus, antagonizing DmGluRA activity
will increase cAMP levels (by relieving inhibition of cAMP after
synaptic stimulation) and will possibly decrease InsP3R-mediated calcium signaling (Fig. 3A) (McBride et al., 2005). We
therefore explored the possibility that the age-dependent cognitive deficits could be rescued by treatment with DmGluRA antagonists as well as lithium.
For this experiment, we used the competitive group II antagonist LY341495 [(2S)-2-amino-2-[(1S,2S)-2-carboxycycloprop1-yl]-3-(xanth-9-yl) propanoic acid] and noncompetitive mGluR5
antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP), as well as
lithium at concentrations found previously to be optimal for
treating dfmr1 mutants (McBride et al., 2005). LY341495 is a very
specific group II antagonist that has been shown to antagonize
DmGluRA in the nanomolar range (Bogdanik et al., 2004). Although MPEP was developed as a noncompetitive antagonist of
the vertebrate group I mGluR5, we have included it in our studies
because the MPEP binding pocket of mGluR5 is more highly
conserved with DmGluRA than any other vertebrate mGluRs
and in previous experiments has similar activity to the known
DmGluRA antagonists LY341495, MPPG [(RS)-␣-methylserineO-phosphate], and MTPG [(RS)-␣-methyl-4-tetrazolylphenylglycine] and shows similar effects to that obtained by genetically
reducing DmGluRA activity (Parmentier et al., 1996; Pagano et
al., 2000; Malherbe et al., 2003; Bogdanik et al., 2004; McBride et
al., 2005; Bolduc et al., 2008; Pan et al., 2008). However, because
it has not been formally shown to be an antagonist of DmGluRA,
it is therefore a putative DmGluRA antagonist.
Two different psn-het genotypes ( psn B3 and psn I2) were
treated with different drugs or non-drug-containing control vehicle solutions from days 6 to 29 of adulthood (after eclosion).
Flies were then transferred to control food containing no drug for
1 d before being tested. Flies were treated with 5 mM NaCl (ionic
control for LiCl), 0.004% DMSO (the vehicle for LY341495), 5
mM LiCl (lithium), 8.6 M MPEP, or 400 nM LY341495. Remarkably, treatment with LiCl, LY341495, or MPEP improved LDT
performance in psn-het flies (Fig. 3H–J ). In contrast, no improvement was observed in flies treated with NaCl or DMSO
(Fig. 3 K, L). These experiments demonstrate that the impairment
in LDT exhibited by the untreated psn-het flies can be prevented
by treatment with lithium, LY341495, and MPEP.
This result with LDT raised the possibility that treatment with
lithium, LY341495, and MPEP might also prevent the agedependent impairment in short-term memory that is exhibited
by the psn-het males. Using the same set of pharmacologic treatments, we found that psn-het flies treated from 6 to 29 d after
eclosion with 5 mM lithium, 8.6 M MPEP, or 400 nM LY341495
demonstrated intact short-term memory (Fig. 3M–O), whereas
those treated with 5 mM NaCl or 0.004% DMSO did not (Fig.
3 P, Q). This result demonstrates that the impairment in short-
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Figure 3. Pharmacologic treatments prevent impairments in learning during training and short-term memory in psn-het flies at 30 d of age. A, A diagram of the putative signaling in our AD model
as well as that from the literature is shown. Arrows indicate activation or increases, and blunt ends indicate inhibition or decreases in activity or protein levels. The double line between wild-type
presenilin and InsP3R indicates an interaction that is neutral or inhibitory. Previous studies have established that group I mGluRs in mammals activate the Gq pathway, whereas the group II and group
III mGluRs activate the Gi signaling pathway. However, there is accumulating evidence that, in mammals, group II mGluRs may activate the Gq signaling pathway and induce long-term depression
in a manner dependent on phospholipase C (PLC) and InsP3R activity (Huang et al., 1997, 1999a,b; Otani et al., 1999, 2002), and group I mGluRs are capable of activating Gi (Kreibich et al., 2004).
We are outlining in this model the actions of DmGluRA in Drosophila, which is known to activate Gi activity, and recent studies indicate that it may also activate Gq activity, just as is the case of group
II mGluRs in mammals (Pan et al., 2008). During activation, Gq activates PLC, which produces DAG and InsP3. DAG and InsP3 can activate PKC and the InsP3R to release calcium from the endoplasmic
reticulum. G␣i activation inhibits adenylate cyclase, thereby preventing an increase in cAMP in response to synaptic stimulation, which prevents the activation of CREB by PKA. Phosphodiesterase
4 (PDE4) breaks down cAMP levels. MPEP is a group I mGluR5 noncompetitive antagonist, which we use at high concentrations to block DmGluRA. LY341495 is a very specific competitive antagonist
of DmGluRA (Bogdanik et al., 2004). LiCl has two main actions at therapeutic levels in cells, one of which is the lowering of InsP3 levels by inhibiting inositol monophosphatase and inositol
polyphosphatase, thereby decreasing the synthesis of InsP3, as well decreasing the rate at which it is recycled (Berridge, 1993; Takei et al., 1998; Williams et al., 2002). The second action of lithium
is the inhibition of GSK-3␤ activity (Klein and Melton, 1996). It is through the aforementioned activities that we propose that these drugs may alter signaling in the Drosophila brain. B–G, Treatment
of WT control flies (OreR) with the DmGluRA antagonist LY341495, the putative DmGluRA antagonist MPEP, or lithium during aging results in impairment of learning during training and short-term
memory. WT control flies were raised on control food and then, after day 6 after eclosion, were placed on food containing either 8.6 M MPEP (MP) or vehicle (Veh) (B, E), 400 nM LY341495 (LY) or
vehicle (Veh) (C, F ), or 5.0 mM lithium (Li) or 5.0 mM NaCl (Na) (D, G) until day 29 and then were tested on day 30. H–Q, Treatment of psn-hets with the DmGluRA antagonist LY341495, the putative
DmGluRA antagonist MPEP, or lithium prevents the age-dependent impairments in learning during training and short-term memory observed in psn-het flies. psn-hets for the psn B3 and psn I2
alleles were raised on control food and then, at day 6 after eclosion, were placed on food containing 8.6 M MPEP (H, M ), 400 nM LY341495 (I, N ), 5.0 mM lithium (J, O), 5.0 mM NaCl (K, P), or 0.004%
DMSO (L, Q) until day 29. Mean ⫾ SEM CIs are plotted. n values are indicated above each bar for all groups. The levels of significance are indicated (*p ⬍ 0.05, **p ⬍ 0.01, ***p ⬍ 0.001). A triangle
indicates a 40% or greater reduction in courtship activity during the training session with a previously mated female (H–L). OreR flies that were treated with MPEP, LY341495, and lithium lacked
detectable learning during training (B–D) or short-term memory (E–G). OreR flies treated with DMSO or NaCl displayed normal learning during training (B–D) and short term memory (E–G).
psn-het flies that were treated with LY341495, MPEP, or lithium demonstrated intact learning during training (H–J ) and intact short-term memory (M–O) at 30 d of age. In contrast, psn-het flies
that were on food containing NaCl or DMSO did not display learning during training (K, L) or short-term memory (P, Q) at 30 d of age.

term memory exhibited by 30-d-old psn-het flies can be prevented by treatments aimed at reducing DmGluRA activity. In
contrast, prolonged treatment of OreR (WT) flies with lithium,
LY341495, and MPEP impaired LDT and short-term memory,
whereas vehicle treatment did not (Fig. 3B–G).
The rescue that we observe when psn-hets are treated with
LY341495, MPEP, or lithium is analogous to the results, we obtained when we treated dfmr1 mutants with these same drugs
(McBride et al., 2005). The similarity of these results suggests that
both psn-hets and dfmr1 mutants display cognitive deficits that
are attributable to enhanced DmGluRA signaling. However, another possibility is that these drug treatments represent some type
of panacea that can rescue any cognitive deficit observed in flies.
With this second possibility in mind, we tested the effect of treating another disease model that displays age-onset loss of shortterm memory with LY341495, MPEP, and lithium.
We have found that expression of human wild-type ␣-synuclein in the mushroom bodies of the fly leads to age-dependent
loss of short-term memory. The mushroom bodies are required
for short-term memory formation in the conditioned courtship
paradigm (Joiner and Griffith, 1999; McBride et al., 1999). In
controls for these flies, short-term memory is intact at 30 d of

age (supplemental Fig. S8 A, available at www.jneurosci.org as
supplemental material). In flies expressing human wild-type
␣-synuclein in the mushroom bodies, short-term memory is
intact at 5 d of age but is impaired at 30 d of age (supplemental
Fig. S8 B, available at www.jneurosci.org as supplemental material). Treatment of these flies with lithium, LY341495, or
MPEP failed to rescue this deficit (supplemental Fig. S8C,D,
available at www.jneurosci.org as supplemental material), indicating that rescue of cognitive deficits in the psn-hets by the
drug treatments is disease specific and may not necessarily be
extrapolated to other disease models displaying age-dependent
cognitive impairments.
Morphological analysis of heterozygous psn brain tissues
The age-dependent impairments in LDT and short-term memory observed in the psn-het flies could possibly be attributable to
the loss of critical neurons as a result of cell death. There is a body
of literature describing loss of synapses and neurons in the brains
of Alzheimer’s patients and in related mouse models (Selkoe,
2002; Mattson, 2004; Walsh and Selkoe, 2004; Hardy, 2006; Small
and Gandy, 2006). To determine whether neuronal loss could
account for the cognitive loss, we performed TUNEL staining on
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Figure 4. Cell death and morphology in 50-d-old psn-het flies. Pharmacologic treatments can reverse impairments in learning during training and short-term memory in psn-het flies. A–C,
Analysis of cell death in aged psn-het, OreR, and Adar mutant brains. TUNEL staining was performed on 50-d-old (negative control) OreR (A), 50-d-old psn-het (B), and 5-d-old (positive control) Adar
mutant brains (C). The brains were examined by confocal microscopy to identify cells undergoing cell death. Foci containing at least one cell undergoing cell death are denoted by white arrows.
Maximum projections, as shown in A–C, made from confocal stacks of entire brains were examined for cell death foci. The number of foci in the central brain region for each brain was scored. The
distribution of the number of cell death foci versus the percentage of brains with such number of foci is shown in D. The majority of psn-het brains lacked any detectable cell death (n ⫽ 41). Those
that did had less than five foci, and there was no consistent location in the brain in which the foci were detected. Similar results were obtained with the OreR brains (n ⫽ 33). Cell death foci were
detected in all Adar mutant brains (n ⫽ 5), which have been described previously to undergo massive cell loss via cell death (Palladino et al., 2000). Fifty-day-old OreR (E) and psn-het (F ) brains were
stained with anti-FasII and examined by confocal microscopy to examine the integrity of the mushroom bodies. This antibody strongly labels the ␣-lobes (white arrow with *, shown in E) and
␤-lobes (arrowhead shown in E) and weakly stains the ␥-lobes (white arrow with #, shown in E). There was no detectable difference in the morphology of the mushroom bodies between OreR (n ⫽
21) and psn-het (n ⫽ 18) brains. G–P, Treatment with LY341495, MPEP, or lithium reverses the age-dependent impairments in learning during training and short-term memory observed in psn-het
flies. psn-hets for the psn B3 and psn I2 alleles were raised on control food and then, at day 30 after eclosion, were placed on food containing 8.6 M MPEP (G, L), 400 nM LY341495 (H, M ), 5.0 mM
lithium (I, N ), 5.0 mM NaCl (J, O), or 0.004% DMSO (K, P) until day 44 and were tested on day 45. Mean ⫾ SEM CIs are plotted, and n values are indicated above each bar for all groups. The levels
of significance are indicated (**p ⬍ 0.01, ***p ⬍ 0.001). A triangle indicates a 40% or greater reduction in courtship activity during the training session with a previously mated female (G–P).
psn-het flies that were treated with LY341495, MPEP, or lithium demonstrated intact learning during training (G–I ) and intact short-term memory (L–N ) at 45 d of age. In contrast, psn-het flies
that were on food containing NaCl or DMSO did not display learning during training (J, K ) or short-term memory (O, P) at 45 d of age.

aged psn-het and control flies. Additionally, we examined the
morphology of the MBs in aged psn-het brains, which are required for short-term memory in the conditioned courtship paradigm (Joiner and Griffith, 1999; McBride et al., 1999). In the
brains of 50-d-old psn-het and OreR flies, we failed to detect any
consistent neuronal loss by TUNEL staining or any gross defects
in MB morphology, indicating that the observed cognitive loss is
most likely not attributable to an age-dependent loss of neurons
or breakdown in MB integrity (Fig. 4 A–F ). Consistent cell death
was observed in 5-d-old (positive control) Adar mutant brains,
which have been shown previously to undergo neuronal cell loss
(Fig. 4C,D) (Palladino et al., 2000).
Reversal of the learning during training and short-term
memory impairments
Because the brain tissue of the aged psn-het flies appears to be
morphologically normal, we considered the possibility that the
age-related behavioral phenotypes could be reversed after they
have already become established. Because the age-dependent impairments in LDT and short-term memory could be prevented by
treatment with LY341495, MPEP, or lithium, we next examined

whether these phenotypes could be reversed by these treatments.
Reversal of the deficits would further indicate that the agedependent cognitive impairments were likely the result of physiological neuronal defects (disrupted intracellular signaling
possibly followed by synapse loss) and not cell death. Using the
same two genotypes ( psn-hets with decreased presenilin activity)
that were subjected to treatments as young adults (Fig. 3), we now
began treatments at day 30 and treated until day 44, testing at 45 d
of age. As above, flies were treated with 5 mM NaCl, 0.004%
DMSO, 5 mM lithium, 8.6 M MPEP, or 400 nM LY341495. Treatment with LY341495 and the putative DmGluRA antagonist
MPEP, as well as lithium, reversed the LDT (Fig. 4G–I ) and
short-term memory (Fig. 4 L–N ) phenotypes in both lines tested.
In contrast, treatment with 5 mM NaCl and the DMSO vehicle
from days 30 to 44 failed to restore normal LDT (Fig. 4 J, K ) or
short-term memory (Fig. 4O,P) in either of the two lines. This
demonstrates that the impairments in LDT and short-term memory exhibited by untreated psn-het flies can be reversed by treatments aimed at reducing DmGluRA activity. This finding is
significant considering that our results may be relevant to the
pathogenesis of Alzheimer’s disease in humans, which is only
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the age-onset cognitive deficits. The results obtained from the DmGluRA heterozygous flies and OreR WT flies treated
with MPEP, LY341495, and lithium, as
described above, all indicate that LDT and
short-term memory are sensitive to a reduction in the activity of this receptor as
well.
Genetic reduction of the inositol
polyphosphate 1-phosphatase prevents
age-onset cognitive defects in the
psn-hets
The results of our pharmacological and
genetic analysis indicate that reducing
DmGluRA signaling rescues age-onset
cognitive deficits in psn-hets. Activation
of DmGluRA through the Gi-coupled
pathway lowers cAMP signaling and
Figure 5. A genetic reduction of DmGluRA rescues short-term memory in psn-het flies at 30 d of age. All flies were tested at 30 d
through potential Gq coupling should inof age for learning during training or short-term memory. Mean ⫾ SEM CIs are plotted, and n values are indicated above each bar
for all groups. The levels of significance are indicated (*p ⬍ 0.05, **p ⬍ 0.01, ***p ⬍ 0.001). A triangle indicates a 40% or greater crease InsP3R-mediated calcium signaling
reduction in courtship activity during the training session with a previously mated female (A–C). DmGluRA112 is a null allele and (Fig. 3A) (McBride et al., 2005). Lithium
DmGluRA2b is a precise excision wild-type control allele of DmGluRA. A, Heterozygosity for the DmGluRA null impairs learning as well as DmGluRA antagonists should
during training. Heterozygosity of DmGluRA rescues learning during training in psn-het B3 (B) and psn-het I2 (C) flies. D, Heterozy- act to increase cAMP-mediated signaling
gosity for the DmGluRA null impairs short-term memory. E, F, Heterozygosity of DmGluRA rescues short-term memory in psn-het by increasing PKA activity and may also
B3 (E) and psn-het I2 (F ) flies.
act to lower InsP3R-mediated calcium signaling (Fig. 3A).
recognized after the onset of cognitive impairments, emphasizing
Previous studies indicate that presenilin proteins bind to the
the need to develop therapeutic strategies that can be impleinositol triphosphate receptor, and expression of mutant forms
mented after the appearance of overt disease symptoms.
of presenilin protein lead to elevated Ca 2⫹ signaling (Stutzmann
et al., 2004; Cheung et al., 2008). The mechanism linking mGluR
Genetic reduction of DmGluRA prevents the onset of LDT and
activity to increased InsP3R activity is shown in Figure 3A. Deshort-term memory defects in aged psn-hets
creased presenilin function by FAD mutations has been shown to
To validate the pharmacological studies described above, we
increase the sensitivity of the InsP3R to InsP3. This means that, in
tested the effect of genetically reducing the level of DmGluRA, the
response to glutamate release after synaptic stimulation, the
only metabotropic glutamate receptor in the Drosophila genome
mGluR will be activated, thereby activating Gq and Gi. The Gq
(Bogdanik et al., 2004), in the psn-het background. Given the
activation will in turn generate InsP3. Because there is less wildreported binding specificities of MPEP, the ability of MPEP
type presenilin present to basally inhibit the sensitivity of the
treatment to phenocopy genetic loss of function in DmGluRA
InsP3R to InsP3, there will be enhanced InsP3R-mediated calcium
mutants, the reported actions of lithium, and the fact that
release in response to physiologic synaptic stimulation. To test
LY341495 has been shown to be a very efficient antagonist of
whether the rescue we observe with genetic and pharmacological
DmGluRA, our drug treatments should reduce DmGluRA sigmanipulation aimed at reducing DmGluRA activity is possibly
naling activity (Bogdanik et al., 2004; McBride et al., 2005). If our
working by lowering enhanced InsP3R activity, we have underobserved rescue is occurring through reduction of DmGluRA
taken manipulations to directly lower InsP3R activity. Toward
signaling activity, our expectation is that genetic reduction of
this goal, we tested the effect of genetically reducing the levels of
DmGluRA should similarly provide some level of rescue of the
the IPPase locus. IPPase as well as IMPase are directly inhibited
age-onset cognitive deficits. To perform this test, we used the
by lithium and are required for InsP3 recycling and synthesis
previously described null allele of DmGluRA (DmGluRA112)
(Berridge, 1993). Genetic reduction of IPPase has been shown to
and precise excision wild-type allele (DmGluRA2b) (Bogdanik
reduce InsP3R signaling in flies (Acharya et al., 1998). We tested
et al., 2004).
two loss-of-function alleles (IPPase1 and IPPase3) (Acharya et al.,
In testing DmGluRA heterozygous flies alone, we found that,
1998) as heterozygotes and found that, at 30 d of age, heterozyat 30 d of age, they display a defect in LDT as well as in short-term
gous males for one allele (IPPase1) lacked significant LDT, but
memory (Fig. 5 A, D), which is similar to what we observed when
heterozygote males for both alleles displayed normal short-term
OreR control flies were treated with LY341495, MPEP, and LiCl
memory (Fig. 6 A, D). When crossed in the psn-het backgrounds,
(Fig. 3B–G). In contrast, the wild-type controls for these lines
the IPPase3 allele prevented loss of LDT in both psn alleles and the
displayed intact LDT and short-term memory at 30 d of age (Fig.
IPPase1 allele prevented this loss of LDT in the psnB3-het back5 A, D). Consistent with our hypothesis, we find that reducing the
ground (Fig. 6 B, C). Both alleles of IPPase prevented loss of shortgene dosage of the DmGluRA receptor by 50% in the psn-het
term memory in both psn-het lines (Fig. 6 E, F ). These results
background prevents the age-onset loss of LDT and short-term
indicate that reduction of IPPase activity can prevent the agememory observed previously at 30 d of age, whereas introduction
onset cognitive deficits observed with the psn-het flies. Next we
of the precise excision allele has no effect (Fig. 5 B, C, E, F ). These
directly tested whether genetic reduction of the InsP3R gene itself
results validate the pharmacological studies described above and
could modulate the age-dependent psn-het phenotypes. To test
again indicate that enhanced DmGluRA signaling contributes to
the effect of genetically reducing InsP3R activity, we used three
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different strength alleles: a hypomorph
(wc361), a molecular null (90B0), and an
antimorphic allele (wc703) (Venkatesh
and Hasan, 1997; Deshpande et al., 2000).
At 30 d of age, heterozygous males for
these alleles display weak (wc703) or no
detectable (wc361 and 90B0) LDT, and all
display normal short-term memory (Fig.
7 A, E). When introduced into the psn-het
background, two of these alleles prevented loss of LDT in the B3 allele of psn
(Fig. 7B–D), and all three alleles prevent
the loss of short-term memory in both psn
alleles at 30 d of age (Fig. 7F–H ). The 90B0
allele continues to prevent this loss of
short-term memory at 40 d of age (Fig.
7I ). These results suggest that a reduction
in InsP3R-mediated Ca 2⫹ release is also
another potential route to ameliorate the
age-onset cognitive deficits associated
with reduced psn levels.

Discussion

Figure 6. A reduction in IPPase expression rescues short-term memory in psn-het flies at 30 d of age. All flies were tested
at 30 d of age for learning during training or short-term memory. Mean ⫾ SEM CIs are plotted, and n values are indicated
above each bar for all groups. The levels of significance are indicated (***p ⬍ 0.001). A triangle indicates a 40% or greater
reduction in courtship activity during the training session with a previously mated female (A–C). A, Heterozygosity for the
IPPase loss-of-function mutant IPPase 1 impairs learning during training, whereas heterozygosity for IPPase 3 does not. B,
Heterozygosity of the IPPase loss-of-function mutants rescues learning during training in psn-het B3. C, Heterozygosity for
the IPPase 3 loss-of-function mutant rescues learning during training in psn-het I2 flies, whereas heterozygosity for IPPase
1 does not. D, Heterozygosity for the IPPase loss-of-function mutants does not impair short-term memory. E, F, Heterozygosity of the IPPase loss-of-function mutants rescues short-term memory in psn-het B3 (E) and psn-het I2 (F ) flies.

To date, all cases of early onset familial
forms of Alzheimer’s disease are attributable to mutations in a single copy of PS1,
PS2, or APP. The large number of different mutations in the PS1 and PS2 genes
that cause AD as well as analysis of the
protease function of FAD mutants is consistent with a loss of
function of PS1 and PS2 as a contributing cause of FAD (De
Strooper, 2007; Hardy, 2007; Shen and Kelleher, 2007). This interpretation of the data suggests that the levels or activity of PS1,
PS2, and APP are crucial for maintaining normal cognition
throughout life. Based on these studies, we have explored
whether this dosage sensitivity of presenilin also exists in Drosophila by examining the cognitive capabilities of psn-het flies in
young and progressively aged psn-het flies. Using a conditioned
courtship paradigm, we have found that deficits in LDT and
short-term memory develop in the psn-het flies with age. These
results further strengthen the hypothesis that some aspects of
FAD and possibly AD may be caused by reduced levels of psn
activity.
The appearance of cognitive deficits before any detectable
neuronal loss
Previous Drosophila AD models have revealed phenotypes that
have parallels with those observed in mouse models and human
patients. These fly models have been based on ectopic expression
of either human tau or human A␤40 or A␤42 peptides and have
been shown to exhibit either hyperphosphorylated tau or aggregations of A␤ that result in neurodegeneration (Wittmann et al.,
2001; Iijima et al., 2004; Mershin et al., 2004; Crowther et al.,
2005). Additionally, it has been demonstrated that expression of
human tau, A␤40, or A␤42 leads to memory deficits (Iijima et al.,
2004; Mershin et al., 2004). In these models, memory deficits are
already present in young adult flies. In contrast, we have uncovered cognitive impairments that are age dependent in the psn-het
flies and occur before any detectable loss of neurons. In studying
the psn-het flies, we detect a clear deficit in LDT and short-term
memory that appeared by 30 d of age. Our examination for cell
death was done on psn-hets that were at least 50 d old, e.g., 20 d
older than when the defects in LDT and short-term memory are

detected. Consistent with this finding, we were able to reverse the
cognitive deficits by initiating treatment at day 30, which would
likely not occur if neuronal loss were the cause of the cognitive
decline.
Although neuronal death is typical of AD, cognitive impairment precedes neuronal death in humans and animal models.
Indeed, recent studies have indicated that synapse loss is better
correlated with memory impairment than the histopathological
hallmarks of plaques and tangles in AD patients (DeKosky and
Scheff, 1990; Terry et al., 1991; Coleman and Yao, 2003). In fact,
memory impairment in Alzheimer’s disease can occur in the absence of plaques and tangles in animal models (Oddo et al., 2003;
Gong et al., 2004; Iijima et al., 2004; Mershin et al., 2004; Billings
et al., 2005) or in FAD patients (Raux et al., 2000; Amtul et al.,
2002; Dermaut et al., 2004; Halliday et al., 2005). Additionally,
within 2– 4 years of AD onset, 25–35% loss of synapses is observed in biopsies of frontal cortex in afflicted patients (Davies et
al., 1987). Furthermore, synaptic function may be impaired even
before synaptic loss occurs in animal models of AD as well as in
patients (Oddo et al., 2003; Palop et al., 2003; Westphalen et al.,
2003; Yao et al., 2003). Thus, our results add to a growing body of
literature that indicates that loss of synaptic plasticity can occur
before or without plaque or tangle formation or neuronal loss.
Our results also demonstrate that this loss of synaptic plasticity
can occur solely as a result of a reduction in psn activity, in the
absence of A␤ accumulation, which does not occur in Drosophila.
Pharmacological rescue of LDT and short-term memory
In a genetic search for pathways affected by a reduction in psn
levels, we identified a strong genetic interaction between psn and
dfmr1. Because this genetic interaction revealed a phenotype in
courtship that was rescued previously in dfmr1 mutant flies by
treatment with DmGluRA antagonists and lithium, we explored
the possibility that these drugs might have efficacy in treating the
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Figure 7. A reduction in InsP3R expression rescues short-term memory in psn-het flies at 30 and 40 d of age. All flies were tested at either 30 or 40 d of age for learning during training or short-term
memory. Mean ⫾ SEM CIs are plotted, and n values are indicated above each bar for all groups. The levels of significance are indicated (*p ⬍ 0.05, ***p ⬍ 0.001). A triangle indicates a 40% or
greater reduction in courtship activity during the training session with a previously mated female (A–D). A, Heterozygosity for the InsP3R loss-of-function mutants 361 and 90B0 impairs learning
during training, whereas heterozygosity for the InsP3R loss-of-function mutant 703 does not completely abrogate learning during training. B, Heterozygosity of the InsP3R loss-of-function mutants
703 and 361 rescues learning during training in psn-het B3 flies. C, Heterozygosity of the InsP3R loss-of-function mutants 703 and 361 fails to rescue learning during training in psn-het I2 flies. D,
Heterozygosity for the InsP3R loss-of-function mutant 90B0 does not rescue learning during training in psn-het B3 or psn-het I2 flies. E, Heterozygosity for the InsP3R loss-of-function mutants does
not impair short-term memory. F, G, Heterozygosity of the InsP3R loss-of-function mutants 703 and 361 rescues short-term memory in psn-het B3 (F ) and psn-het I2 (G) flies. H, I, Heterozygosity
of the InsP3R loss-of-function mutant 90B0 rescues short-term memory in psn-het B3 and psn-het I2 flies at 30 d (H ) and 40 d (I ) of age.

age-onset phenotypes of the psn-hets. Consistent with our findings, recent studies of mouse Alzheimer’s disease models and of
afflicted humans have suggested that calcium signaling is enhanced and cAMP signaling may be decreased (Selkoe, 2002;
Gong et al., 2004; Mattson, 2004; Walsh and Selkoe, 2004). We
propose that these two signaling pathways are downstream of
DmGluRA signaling (Fig. 3A).
In our studies, we demonstrated that treatment with lithium,
the DmGluRA antagonist LY341495, and the putative DmGluRA
antagonist MPEP prevented age-dependent impairments in psnhet flies at 30 d of age and can reverse LDT and short-term memory impairments if treatment is begun at 30 d of age, a time point
after the deficits appear. These treatments should function to
counteract decreased cAMP signaling and may counteract increased InsP3R-mediated calcium release (Fig. 3A).
The successful treatments of the psn-hets are consistent with
results from two studies in mouse models of AD, both of which
demonstrated improved cognition through pharmacological
treatment without effects on A␤ plaque burden. First, Gong et al.
(2004) demonstrated that increasing cAMP levels can rescue behavioral plasticity, and second, Malm et al. (2007) showed that
indirectly inhibiting GSK-3␤ activity rescues behavioral plasticity. The results from our studies demonstrate that treatment with
lithium, LY341495, or MPEP can rescue cognitive loss attributable to reduced psn activity, a condition we propose exists in FAD
and possibly sporadic AD. We therefore suggest that lithium and
mGluR antagonists should be considered for additional study as
potential agents for therapeutic treatment of cognitive deficits
associated with Alzheimer’s disease.
Genetic reduction of the InsP3R pathway also prevents
age-onset cognitive decline
We wanted to further elucidate the pathways downstream of
DmGluRA that might be responsible for the rescue observed

when the DmGluRA activity is reduced, genetically or pharmacologically. Lithium treatment and decreases in mGluR activity
both lower InsP3R-mediated calcium signaling in vertebrates. In
our genetic tests, we found that genetic reduction of InsP3Rmediated calcium signaling provides similar rescue to that observed when DmGluRA activity is reduced genetically. By testing
multiple alleles of IPPase as well as InsP3R, we found that, in
general, loss-of-function mutants of both genes provided rescue
of age-onset deficits of LDT and short-term memory in the
psn-hets.
The InsP3R is an endoplasmic reticulum localized Ca 2⫹ channel that releases Ca 2⫹ from the endoplasmic reticulum into the
cytoplasm in response to InsP3 binding. It was demonstrated
recently that FAD mutations of presenilin expressed in cells resulted in increased sensitivity to InsP3-mediated Ca 2⫹ release,
leading to enhanced cytoplasmic concentrations of Ca 2⫹
(Cheung et al., 2008). These results fit with previous studies in
which both FAD mutations and loss of functional activity of wildtype presenilin have been linked to increases in InsP3R-mediated
calcium signaling in cell culture and transgenic mouse models of
AD (Peterson et al., 1988; Huang et al., 1991; Ito et al., 1994;
Tatebayashi et al., 1995; Hirashima et al., 1996; Etcheberrigaray et
al., 1998; Stutzmann et al., 2004). Our results demonstrating that
pharmacological treatment with drugs that should reduce DmGluRA activity, as well as genetic reduction of DmGluRA, IPPase,
and the InsP3R are consistent with the hypothesis that reduction
in this Ca 2⫹ release mechanism might ameliorate the age-onset
cognitive deficits associated with AD. Moreover, these results
provide the first test of the pathogenic nature of enhanced
InsP3R-mediated calcium signaling in AD. Previous studies have
speculated on the pathogenic nature of this calcium signaling but
could not rule out the possibility that these changes were compensatory in AD. Herein we were able to demonstrate a rescue of
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cognitive deficits by decreasing this signaling, indicating that upregulation of this pathway leads to cognitive loss over time.
In conclusion, our study of Drosophila psn haploinsufficiency
contributes to the understanding of age-onset cognitive loss and
provides a new model to study aspects of Alzheimer’s disease. We
examined several phases of learning and memory in young and
older Drosophila adults and identified age-dependent cognitive
impairments in learning during training and short-term memory. We have demonstrated that lithium treatment can rescue
cognition in an animal model of AD. These results are in contrast
to a previous attempt with lithium treatment in a mouse
model of AD that failed to rescue working memory impairments (Caccamo et al., 2007). We have additionally identified
and demonstrated the efficacy of mGluR antagonists as a novel
therapeutic target for the treatment of the cognitive deficits
associated with AD. Our results also indicate that lowering
IPPase activity or lowering InsP3R-mediated calcium signaling can rescue cognitive loss. Finally, this study demonstrates
that reversal of memory impairment after onset can be obtained by treatment with either mGluR antagonists or lithium.
These results suggest novel therapeutic targets that may have
relevance for treatment of AD to be explored in other animal
models.
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